Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Guardant Health, a precision oncology leader, will participate virtually in the Morgan Stanley Global Healthcare Conference on September 9, 2021, at 1:15 p.m. PT. Interested individuals can access a live and archived webcast via the company’s website. Guardant Health focuses on cancer care through advanced tests like Guardant360 and Guardant Reveal, aiming to improve patient outcomes and reduce healthcare costs. The company is dedicated to enhancing cancer screening, particularly for asymptomatic individuals.

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.

Guardant Health’s management is scheduled to participate in a fireside chat on Thursday, September 9 at 1:15 p.m. Pacific Time / 4:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360^®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI^® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com

Media Contact:
Anna Czene
press@guardanthealth.com

FAQ

When is Guardant Health's participation in the Morgan Stanley Global Healthcare Conference?

Guardant Health will participate in the Morgan Stanley Global Healthcare Conference on September 9, 2021, at 1:15 p.m. PT.

How can I access Guardant Health's presentation at the conference?

You can access a live and archived webcast of Guardant Health's presentation on their website in the 'Investors' section.

What is the purpose of Guardant Health's tests?

Guardant Health's tests focus on improving cancer patient outcomes, reducing healthcare costs, and aiding in early cancer screening.

What is the stock symbol for Guardant Health?

The stock symbol for Guardant Health is GH.

What tests does Guardant Health offer?

Guardant Health offers tests such as Guardant360, Guardant360 CDx, and Guardant Reveal, targeting both advanced and early-stage cancer patients.